Literature DB >> 10398102

Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes.

B J Iacopetta1, R Soong, A K House, R Hamelin.   

Abstract

The replication error phenotype (RER+) represents an important new form of genetic alteration characterized by widespread instability in repetitive nucleotide sequences. The aim of this study was to compare the features of RER+ gastric tumours with those of RER+ colonic tumours. RER status was determined by analysis of size alterations in the BAT-26 mononucleotide repeat microsatellite. Twelve of 121 (10 per cent) gastric carcinomas from a low-incidence region were found to be RER+. BAT-26 instability was associated with tumours showing an absence of nodal invasion ( p=0.009) and with a trend for improved prognosis. These tumours were more frequent in older, female patients. Frameshift mutations in mononucleotide repeat sequences within the transforming growth factor-beta receptor II (RII), insulin-like growth factor II receptor (IGFIIR), and BAX genes were observed in 83, 33, and 25 per cent, respectively, of RER+ tumours. Only 1/12 (8 per cent) RER+ tumours contained a p53 gene mutation compared with 29/109 (27 per cent) RER- tumours. RER+ gastric carcinomas therefore share several important features with RER+ colonic tumours, including less frequent nodal invasion, improved prognosis, a similar frequency of mutation in growth control genes containing repetitive nucleotide sequences, and a low frequency of mutation of the p53 tumour suppressor gene. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398102     DOI: 10.1002/(SICI)1096-9896(199903)187:4<428::AID-PATH264>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

Review 1.  Genomic and genetic alterations influence the progression of gastric cancer.

Authors:  Stefania Nobili; Lorenzo Bruno; Ida Landini; Cristina Napoli; Paolo Bechi; Francesco Tonelli; Carlos A Rubio; Enrico Mini; Gabriella Nesi
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

2.  The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type.

Authors:  Stefano Barbi; Ivana Cataldo; Giovanni De Manzoni; Samantha Bersani; Simona Lamba; Silvia Mattuzzi; Alberto Bardelli; Aldo Scarpa
Journal:  J Exp Clin Cancer Res       Date:  2010-04-16

3.  Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo.

Authors:  R B Luwor; B Baradaran; L E Taylor; J Iaria; T V Nheu; N Amiry; C M Hovens; B Wang; A H Kaye; H-J Zhu
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

Review 4.  Genetic aspects of gastric cancer instability.

Authors:  Petra Hudler
Journal:  ScientificWorldJournal       Date:  2012-04-19

5.  Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).

Authors:  Ziliang Jin; Weihua Jiang; Liwei Wang
Journal:  Oncol Lett       Date:  2015-02-12       Impact factor: 2.967

6.  Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.

Authors:  Kunitoshi Shigeyasu; Takeshi Nagasaka; Yoshiko Mori; Naosuke Yokomichi; Takashi Kawai; Tomokazu Fuji; Keisuke Kimura; Yuzo Umeda; Shunsuke Kagawa; Ajay Goel; Toshiyoshi Fujiwara
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

7.  BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.

Authors:  Safoora Deihimi; Avital Lev; Michael Slifker; Elena Shagisultanova; Qifang Xu; Kyungsuk Jung; Namrata Vijayvergia; Eric A Ross; Joanne Xiu; Jeffrey Swensen; Zoran Gatalica; Mark Andrake; Roland L Dunbrack; Wafik S El-Deiry
Journal:  Oncotarget       Date:  2017-06-20

8.  Clinicopathologic and immunohistochemistry characterization of synchronous multiple primary gastric adenocarcinoma.

Authors:  Ulysses Ribeiro; Uana M Jorge; Adriana V Safatle-Ribeiro; Osmar K Yagi; Cristovam Scapulatempo; Rodrigo O Perez; Carlos E P Corbett; Venâncio A F Alves; Bruno Zilberstein; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.